You are about to leave the Clinical Value website now.
Precision Oncology
Injection or Infusion? How biologic cancer medicines can be given
Read Article
Breaking barriers to precision oncology implementation with digital solutions
While precision oncology has shown great promise, there are still barriers to its implementation, such as data fragmentation, staff shortages and time, funding, and lack of standardization. The use of…
Read Article
The impact of the multi-disciplinary molecular tumour board and integrative next generation…
The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular Tumour Board (MTB) was…
Read Article
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board…
These recommendations provide a critical guidance from NGS panel testing to final treatment decision based on MTB discussion.
Read ArticleInjection or Infusion? How biologic cancer medicines can be given
Breaking barriers to precision oncology implementation with digital solutions
The impact of the multi-disciplinary molecular tumour board and integrative…
Recommendations for the Use of Next-Generation Sequencing and the Molecular…
Globally, cancer is the leading cause of death, accounting for nearly 1 in 6 deaths in 2020 with majority coming from Asia. Given today’s ageing population, and emerging factors like diet and environment, the burden of cancer is only projected to increase.
To tackle the rising cancer burden and increase the chances of survival, the integration of diagnostic testing and treatment is key. In the era of precision oncology, genomic profiling, clinical decision support solutions, and multidisciplinary partnership can enable early diagnosis and personalised treatment, presenting the opportunity to improve the lives of millions of people around the world.